Vascular Biogenics Price Prediction

Intrinsic Valuation Low Real High 0.01 0.15 7.89 Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Vascular Biogenics. Your research has to be compared to or analyzed against Vascular Biogenics' peers to derive any actionable benefits. When done correctly, Vascular Biogenics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Vascular Biogenics.

Vascular Biogenics After-Hype Price Prediction Density Analysis

Vascular Biogenics Estimiated After-Hype Price Volatility

Vascular Biogenics Stock Price Prediction Analysis

Vascular Biogenics Hype Timeline

Vascular Biogenics is at this time traded for 0.16. The entity has historical hype elasticity of 0.01 and average elasticity to hype of competition of 0.2. Vascular is expected to increase in value after the next headline with the price projected to jump to 0.17 or above. The average volatility of media hype impact on the company stock price is over 100%. The price appreciation on the next news is projected to be 6.25% whereas the daily expected return is at this time at -0.55%. The volatility of related hype on Vascular Biogenics is about 2127.84% with expected price after next announcement by competition of 0.36. Given the investment horizon of 90 days the next expected press release will be in about 3 days. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Vascular Biogenics Related Hype Analysis

Vascular Biogenics Additional Predictive Modules

Most predictive techniques to examine Vascular price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Vascular using various technical indicators. When you analyze Vascular charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The number of cover stories for Vascular Biogenics depends on current market conditions and Vascular Biogenics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Vascular Biogenics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Vascular Biogenics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Vascular Biogenics' future price predictability will typically decrease when Vascular Biogenics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Vascular Biogenics often depends not only on the future outlook of the potential Vascular Biogenics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vascular Biogenics' indicators that are reflective of the short sentiment are summarized in the table below.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

If you are still planning to invest in Vascular Biogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vascular Biogenics' history and understand the potential risks before investing.